Related Experiment Video
Updated: Jul 1, 2025

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Host range expansion of Acinetobacter phage vB_Ab4_Hep4 driven by a spontaneous tail tubular mutation
Penggang He1, Feng Cao2, Qianyu Qu1
1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Abstract:
Bacteriophages (phages) represent promising alternative treatments against multidrug-resistant Acinetobacter baumannii (MDRAB) infections. The application of phages as antibacterial agents is limited by their generally narrow host ranges, so changing or expanding the host ranges of phages is beneficial for phage therapy. Multiple studies have identified that phage tail fiber protein mediates the recognition and binding to the host as receptor binding protein in phage infection. However, the tail tubular-dependent host specificity of phages has not been studied well. In this study, we isolated and characterized a novel lytic phage, vB_Ab4_Hep4, specifically infecting MDRAB strains. Meanwhile, we identified a spontaneous mutant of the phage, vB_Ab4_Hep4-M, which revealed an expanded host range compared to the wild-type phage. A single mutation of G to C was detected in the gene encoding the phage tail tubular protein B and thus resulted in an aspartate to histidine change. We further demonstrated that the host range expansion of the phage mutant is driven by the spontaneous mutation of guanine to cytosine using expressed tail tubular protein B. Moreover, we established that the bacterial capsule is the receptor for phage Abp4 and Abp4-M by identifying mutant genes in phage-resistant strains. In conclusion, our study provided a detailed description of phage vB_Ab4_Hep4 and revealed the tail tubular-dependent host specificity in A. baumannii phages, which may provide new insights into extending the host ranges of phages by gene-modifying tail tubular proteins.
Insights
This study details a novel bacteriophage, vB_Ab4_Hep4, effective against multidrug-resistant Acinetobacter baumannii. A mutation in its tail tubular protein B expanded the phage
Area of Science:
- Microbiology
- Virology
- Bacteriophage Therapy
Background:
- Multidrug-resistant Acinetobacter baumannii (MDRAB) poses a significant threat.
- Bacteriophages (phages) are potential alternatives to antibiotics for MDRAB infections.
- Phage host range limitations hinder their therapeutic application.
Purpose of the Study:
- To characterize a novel lytic phage, vB_Ab4_Hep4, targeting MDRAB.
- To investigate the mechanism of host range expansion in a mutant phage, vB_Ab4_Hep4-M.
- To elucidate the role of tail tubular proteins in phage host specificity.
Main Methods:
- Isolation and characterization of lytic phage vB_Ab4_Hep4 and its mutant vB_Ab4_Hep4-M.
- Genetic analysis to identify mutations responsible for host range expansion.
- Expression of tail tubular protein B to confirm mutation effects.
- Identification of bacterial capsule as the phage receptor.
Main Results:
- A spontaneous mutant phage, vB_Ab4_Hep4-M, exhibited an expanded host range.
- A single G-to-C mutation in the tail tubular protein B gene (Asp to His) drove host range expansion.
- The bacterial capsule was identified as the receptor for both wild-type and mutant phages.
- Tail tubular protein B plays a crucial role in determining A. baumannii phage host specificity.
Conclusions:
- Phage vB_Ab4_Hep4 is a promising agent against MDRAB.
- Tail tubular protein modification offers a strategy to broaden phage host ranges for enhanced phage therapy.
- Understanding tail tubular-dependent specificity is key for engineering phages with improved therapeutic potential.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages

